A3P & BPSA - Single Use Systems

X ray / Integrity testing / Contamination management (PFAS) / Standardization / Single Use sensor involvement

A3P & BPSA - Single Use Systems

When?

December 02 & 03, 2025

Where?

Lyon, France

Format?

Conferences, Partner Sessions & Exhibition

Introduction

This A3P event follows extensive work by members of the A3P Single-Use Systems Common Interest Group (CIG) and is being organized this year in partnership with the Bio-Process Systems Alliance (BPSA).
The Bio-Process Systems Alliance (BPSA) was established in 2005 as an international industry-led association to encourage and accelerate the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines.

In a regulatory context surrounding the use of single-use systems, this event will give you the keys to improving your process control.
Come and join single-use system professionals to share and discuss system harmonization, eco-design and future regulatory challenges, PFAS contaminants, integrity testing, and many other topics.

The program and structure of this event are based on the exchange and sharing of experiences through:
- 12 conferences
- 3 interactive workshops
- an exhibition of the main suppliers of single-use products
The main topics covered will be:
- new market trends, system harmonization, and sustainability 
Numerous user feedback reports will be presented, encouraging the sharing and exchange of best practices.

🇬🇧Simultaneous translation into English will be provided during the event.🇬🇧
REGISTRATION

PROGRAM

Related articles

The Impact of Single-Use Technologies on the Environment: Myths and Reality

La Vague 49 / April 2016
The implementation of single-use addresses the main challenges of the biopharmaceutical industry, e.g. fast and straightforward capacity adaptation, cost savings, risk mitigation as no cleaning is required. Because single-use bags offer multiple technical and economic benefits (1) they are broadly adopted by the entire biopharmaceutical industry to achieve rapid and flexible development and commercial production of monoclonal antibodies, recombinant proteins and vaccines.
Button

Container integrity testing (CCIT) for single-use systems

La Vague 55 / October 2017
Historically, container integrity tests were performed using the dye test method or the microbiological method (microbial challenge). The article in the PDA Journal(1) entitled “Development of a Dye Ingress Method to Assess Container-Closure Integrity Correlation to Microbial Ingress” is one of the reference texts in this field.
Button

Implementation of Single-Use in Drug Substance filling before transportation: Product Development case study.

La Vague 58 / July 2018
The development of a new product or service is better done as a collaboration between the developer and the potential end user/s. Systems developed in isolation often end up answering questions no one has ever asked, or fails to develop a full solution. With that in mind the enclosed article discusses the product development cycle of a system for bulk filtration of Active Pharmaceutical Ingredients (API’s).
Button